BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Malvern Instruments’s Zetasizer Nano Critical To Development Of Brain Tumor Illumination

  December 3, 2009

   · 

  2 min read
• Lengthy Lactation Lightens Metabolic Syndrome Risk

  December 3, 2009

   · 

  1 min read
• Pharm Country

  Medidata Solutions, Inc. Introduces Rave Safety Gateway

  December 3, 2009

   · 

  1 min read
• Drug Development

  Hyperion Therapeutics Enrolls First Patient in Phase II Hepatic Encephalopathy Trial

  December 3, 2009

   · 

  1 min read
• Business

  NOXXON Pharma AG Achieves Milestone in Partnership with Eli Lilly and Company

  December 3, 2009

   · 

  1 min read
• Beike Bio-Technology Co. Ltd CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India

  December 3, 2009

   · 

  3 min read
• Deals

  Luminetx Signs Definitive Acquisition Agreement with Christie Digital Systems(R)

  December 3, 2009

   · 

  1 min read
• imaGenes to Bundle Data with CLC bio’s software for High-Throughput Sequencing Data Analysis

  December 3, 2009

   · 

  1 min read
• Drug Development

  Celsion Corporation Provides Update on Progress of ThermoDox(R) Phase III Study for Primary Liver Cancer

  December 3, 2009

   · 

  1 min read
• Drug Development

  Cubist Pharmaceuticals, Inc. Closes Enrollment Early in CONSERV(TM)-1 and CONSERV-2 Ph. 2 Trials for CB-500,929 (Ecallantide), in Development as Therapy to Reduce Bleeding in On-Pump Cardiac Surgery

  December 3, 2009

   · 

  1 min read